CSIMarket



Beam Therapeutics Inc   (BEAM)
Other Ticker:  
 
 

BEAM's Free Cash Flow Growth by Quarter and Year

Beam Therapeutics Inc 's Free Cash Flow results by quarter and year




BEAM Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 1.83 -24.30 -296.23
III Quarter September - 3.01 -21.21 -
II Quarter June - -32.53 -22.84 111.60
I Quarter March 218.49 -38.58 -27.39 0.10
FY   218.49 -66.27 -95.74 -184.53



BEAM Free Cash Flow first quarter 2022 Y/Y Growth Comment
Beam Therapeutics Inc in the first quarter 2022 achieved Free Cash Flow of $ 218.49 millions compare to free cash outflow recorded in same quarter a year ago.

According to the results reported in the first quarter 2022, Beam Therapeutics Inc achieved the best Free Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Beam Therapeutics Inc ' s Free Cash Flow no change of % ranks overall at the positon no. 0 in the first quarter 2022.




BEAM Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - 98.93 %
I Quarter March - - - -99.76 %
FY   - - - -

Financial Statements
Beam Therapeutics Inc 's first quarter 2022 Free Cash Flow $ 218.49 millions BEAM's Income Statement
Beam Therapeutics Inc 's first quarter 2021 Free Cash Flow $ -38.58 millions Quarterly BEAM's Income Statement
New: More BEAM's historic Free Cash Flow Growth >>


BEAM Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -39.2 % - -
III Quarter September - - - -
II Quarter June - - - 111500 %
I Quarter March 11839.34 % - - -
FY (Year on Year)   - - - -




Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0

Free Cash Flow Y/Y Growth Statistics
High Average Low
401.55 % -1.7 % -100 %
(Sep. 30, 2011)   (Dec 31 2013)
Free Cash Flow first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Free Cash Flow Y/Y Growth Statistics
High Average Low
401.55 % -1.7 % -100 %
(Sep. 30, 2011)   (Dec 31 2013)

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Beam Therapeutics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
111500 % 8884.89 % -100 %
(Sep 30 2013)  


BEAM's I. Quarter Q/Q Free Cash Flow Comment
Beam Therapeutics Inc achieved in the I. Quarter 2022 above company average sequential Free Cash Flow doubling of 11839.34%, to $ 218.49 millions, from $1.83 millions in the forth quarter.
Beam Therapeutics Inc is undergoing a remarkable growth, not only recording above regular gain, and additionally increasing pace.

Within Biotechnology & Pharmaceuticals industry Beam Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Beam Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1.


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #1
Healthcare Sector #1
Overall #1
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #1
Healthcare Sector #1
Overall #1
Free Cash Flow Q/Q Growth Statistics
High Average Low
111500 % 8884.89 % -100 %
(Sep 30 2013)  


BEAM's I. Quarter Q/Q Free Cash Flow Comment
Beam Therapeutics Inc achieved in the I. Quarter 2022 above company average sequential Free Cash Flow doubling of 11839.34%, to $ 218.49 millions, from $1.83 millions in the forth quarter.
Biotechnology & Pharmaceuticals company is going from strength to strength, not just recording better then average increase, and also accelerating rate, Elizabetta Romano, Biotechnology & Pharmaceuticals industry expert situated in Rome mentioned.

Within Biotechnology & Pharmaceuticals industry Beam Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Beam Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is 1.


Beam Therapeutics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Free Cash Flow 12 Months Ending $ 233.39 $ -19.46 $ -50.83 $ -78.01 $ -82.14
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
In the Mar 31 2022 period, Beam Therapeutics Inc had cumulative twelve months Free Cash Flow of $ 233 millions compare to free cash outflow of $ -82 millions a year ago.

Beam Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
305.68 %
11.96 %
-89.19 %
(Sep. 30, 2011)  

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
311.54 %
19.25 %
-89.03 %
(Jun 30 2012)  


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0
Cumulative Free Cash Flow growth Comment
In the Mar 31 2022 period, Beam Therapeutics Inc had cumulative twelve months Free Cash Flow of $ 233 millions compare to free cash outflow of $ -82 millions a year ago.

Beam Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
305.68 %
11.96 %
-89.19 %
(Sep. 30, 2011)  


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
311.54 %
19.25 %
-89.03 %
(Jun 30 2012)  


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
BEAM's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for BEAM's Competitors
Free Cash Flow Growth for Beam Therapeutics Inc 's Suppliers
Free Cash Flow Growth for BEAM's Customers

You may also want to know
BEAM's Annual Growth Rates BEAM's Profitability Ratios BEAM's Asset Turnover Ratio BEAM's Dividend Growth
BEAM's Roe BEAM's Valuation Ratios BEAM's Financial Strength Ratios BEAM's Dividend Payout Ratio
BEAM's Roa BEAM's Inventory Turnover Ratio BEAM's Growth Rates BEAM's Dividend Comparisons



Companies with similar Free Cash Flow doubling for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2022
Bristol myers Squibb Company-0.31%$ -0.314 millions
Bio techne Corp-2.32%$ -2.321 millions
Edwards Lifesciences Corporation-2.40%$ -2.396 millions
Chemed Corporation-5.27%$ -5.275 millions
Moderna Inc -7.00%$ -7.001 millions
Idexx Laboratories Inc-7.81%$ -7.809 millions
Abcellera Biologics Inc -8.51%$ -8.513 millions
Abiomed Inc.-8.68%$ -8.676 millions
Utah Medical Products Inc-8.80%$ -8.802 millions
Amedisys Inc-9.96%$ -9.964 millions
Sotera Health Company-11.03%$ -11.026 millions
Royalty Pharma Plc-12.51%$ -12.513 millions
Ironwood Pharmaceuticals inc -12.99%$ -12.986 millions
Quidel Corporation-14.43%$ -14.431 millions
Endo International Plc-17.44%$ -17.438 millions
Amneal Pharmaceuticals Inc -18.76%$ -18.757 millions
Fulgent Genetics Inc -19.20%$ -19.199 millions
Medpace Holdings Inc -19.30%$ -19.301 millions
Bruker Corporation-20.61%$ -20.612 millions
Abbott Laboratories-21.69%$ -21.691 millions
Lemaitre Vascular Inc-22.44%$ -22.440 millions
Zoetis Inc -22.75%$ -22.750 millions
Axon Enterprise inc -27.86%$ -27.856 millions
Gilead Sciences Inc -29.50%$ -29.502 millions
Hca Healthcare Inc -32.34%$ -32.344 millions
U S Physical Therapy Inc-34.09%$ -34.090 millions
Quest Diagnostics Inc-34.34%$ -34.337 millions
Integra Lifesciences Holdings Corp-35.81%$ -35.809 millions
Co diagnostics Inc -36.38%$ -36.383 millions
Rackspace Technology Inc -37.50%$ -37.500 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BAP's Profile

Stock Price

BAP's Financials

Business Description

Fundamentals

Charts & Quotes

BAP's News

Suppliers

BAP's Competitors

Customers & Markets

Economic Indicators

BAP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071